Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT04679090

Unknown

Physical Activity Levels and Functional Improvement in Breast Cancer Survivors (CanEX)

Breast Cancer
NCT02139358

Completed

Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer

Breast Cancer
NCT01690702

Completed

Study of Nab-Paclitaxel in High Risk Early Breast Cancer (GAIN-2)

Breast Cancer
NCT03413332

Unknown

Web-Based Communication Education for Breast Cancer Survivorship Care

Breast Cancer
NCT02730091

Terminated

A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease (VICTORIANE)

Breast Cancer
NCT04731805

Completed

Moving On - An RCT to Test Physical Therapy Education

Breast Cancer
NCT01479101

Completed

NBRST: Prospective Neo-adjuvant REGISTRY Trial (NBRST)

Breast Cancer
NCT02635737

Completed

Magnetic Seed Localisation of Breast Cancers (Sentimark)

Breast Cancer
NCT04683770

Unknown

Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer

Breast Cancer
NCT02716467

Completed

Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial

Breast Cancer
NCT00006425

Completed

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study

Breast Cancer
NCT04640454

Completed

Assessment of Nipple Sparing Mastectomy as a Treatment Option for Breast Cancer

Breast Cancer
NCT02336737

Completed

SentiMag® Intraoperative Comparison in Breast Cancer (SentiMagIC)

Breast Cancer
NCT03780491

Completed

Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care

Breast Cancer
NCT00796107

Terminated

A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer

Breast Cancer
NCT01491737

Completed

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (PERTAIN)

Breast Cancer
NCT03846583

Withdrawn

Tucatinib + Abemaciclib + Herceptin for HER2+ MBC

Breast Cancer
NCT03394287

Completed

A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC

Breast Cancer
NCT00574587

Completed

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Breast Cancer
NCT00836186

Completed

Cytokine Expression During Radiation for Breast Cancer

Breast Cancer
NCT01525589

Completed

A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer

Breast Cancer
NCT02900469

Completed

Presurgical Trial of Denosumab in Breast Cancer

Breast Cancer
NCT01017549

Completed

Post Market Study Using the Xoft Axxent System

Breast Cancer
NCT00206518

Completed

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients (TACAC)

Breast Cancer
NCT02287675

Completed

Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer (Lymphoseek)

Breast Cancer
NCT01641562

Completed

Diagnosis and Prediction of Taxanes Induced Cardiac Dysfunction (CARDIOTAX)

Breast Cancer
NCT04474652

Suspended

Guide for Prioritisation of Patients for Referral to Breast Clinics

Breast Cancer
NCT01950182

Completed

Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer (SYSUCC-002)

Breast Cancer
NCT04072718

Completed

Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer (SIBART-BC)

Breast Cancer
NCT03183206

Completed

Safety and Efficiency of γδ T Cell Against Breast Cancer

Breast Cancer
NCT04463459

Unknown

Effect of Vitamin C and E in Breast Cancer Patients Undergoing Chemotherapy

Breast Cancer
NCT02628132

Completed

Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients

Breast Cancer
NCT02941614

Completed

Implementing Systematic Distress Screening in Breast Cancer

Breast Cancer
NCT02692209

Completed

A Multi-Reader Multi-Case Pivotal Trial

Breast Cancer
NCT02644382

Completed

Improving Surgical Decision-making in Young Women With Breast Cancer

Breast Cancer
NCT03491917

Completed

Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer

Breast Cancer
NCT04427215

Unknown

Complementary and Alternative Medicine on Mental Health in Breast Cancer Patients

Breast Cancer
NCT00090480

Terminated

Vaccine Treatment for Advanced Breast Cancer

Breast Cancer
NCT03082456

Completed

Molecular Breast Imaging in Screening Breast Cancer

Breast Cancer
NCT03065712

Withdrawn

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Breast Cancer
NCT01532960

Terminated

Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer (Breast 41)

Breast Cancer
NCT02559362

Completed

Study on Breast Cancer Patient Perspectives of Exercise

Breast Cancer
NCT03273426

Completed

Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.

Breast Neoplasm
NCT00238316

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

Breast Cancer
NCT00002542

Completed

Tamoxifen in Treating Women With High-Risk Breast Cancer

Breast Cancer
NCT04328194

Unknown

Autotaxin (ATX) as a Marker for Breast Cancer

Breast Cancer
NCT00854789

Completed

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer

Breast Cancer
NCT03479385

Completed

Integrative Approaches to Cancer Survivorship: Project 3 (IACS2)

Breast Cancer
NCT03847623

Unknown

Effect of Preoperative Curcumin in Breast Cancer Patients (EPC)

Breast Cancer
NCT02275871

Terminated

Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations